Precision Gene Activation Technique Mitigates Off-Target Effects for Cellular Therapies

Cellular therapies have immense potential, but it has proven challenging to design activation proteins, known as transcription factors, that can specifically trigger bioengineered genes without inadvertently activating the cell's natural genes. Addressing this concern, a team led by bioengineers from Rice University has developed a method that draws inspiration from nature to significantly reduce "off-target" gene activations.

By intentionally weakening transcription factors, the research team achieved remarkable results, according to Caleb Bashor, co-senior author of the paper published in Cell, who explained that by reducing the overall binding strength of transcription factors, the likelihood of them binding off-target genes diminishes considerably. This seemingly counterintuitive approach stems from the strategy of employing multiple weakened transcription factors in a team, leveraging a cooperative assembly phenomenon.

Transcription factors play a critical role in gene circuits, the cooperative sets of genes that perform specific functions. In gene circuitry, transcription factors link different genes, controlling their expression. Bashor's team has demonstrated this concept in diverse circuits, enabling programmable logic, signal processing, and analog-to-digital conversion, among other complex tasks. By utilizing cooperative assembly, transcription factors only activate target genes when they form large protein complexes with other factors.

Bashor highlights the innovation's broader implications, using the example of cell-based therapies. Ensuring engineered cells flourish and multiply within patients is crucial for therapeutic efficacy. By mitigating off-target interactions, the new approach enhances the likelihood of cellular therapies' success. This method not only normalizes gene circuits but also "stabilizes" them, ensuring sustained functionality within cells.